David M. Lubaroff

Professor of Urology and Microbiology
Director, Urology Research
Director, Prostate Cancer Research Program
Associate Director for Research Infrastructure, Holden Comprehensive Cancer Center

University of Iowa College of Medicine
375 Newton Road
3210 MERF
Iowa City, IA 52242
(319) 335-8423
(319) 353-4556 - Fax


1961 B.S. University of the Sciences in Philadelphia
1964 M.S. Georgetown University
1967 Ph.D. Yale University

Professional and Academic Positions Held

1967-1969 Postdoctoral Fellow, University of Pennsylvania
1969-1970 Associate in Pathology, University of Pennsylvania
1970- 1973 Assistant Professor Pathology and Medical Genetics, University of Pennsylvania
1971-1973 Member, Immunology Graduate Group, University of Pennsylvania
1973-1977 Assistant Professor of Urology (Microbiology), University of Iowa
1977-1982 Associate Professor of Urology (Microbiology), University of Iowa
1973-1986 Research Immunologist, Veterans Administration Medical Center, Iowa City, Iowa
1986-1991 Associate Career Scientist, Veterans Administration Medical Center, Iowa City, Iowa
1991-present Research Immunologist, Veterans Administration Medical Center, Iowa City, Iowa
1977-present Director of Urology Research, University of Iowa
1982-present Professor of Urology (Microbiology), University of Iowa
1992-present Professor, Interdisciplinary Immunology Program, University of Iowa
1994-present Member, University of Iowa Cancer Center
1995-present Director, Prostate Cancer Research Program, University of Iowa
1997-present Associate Director for Research Infrastructure, Holden Comprehensive Cancer Center at the University of Iowa
2001-present Program Leader, Prostate Cancer Research Program, Holden Comprehensive Cancer Center at the University of Iowa

Ph.D. Theses Directed

1974-1977 Charles Schlagel
1974-1978 Dale Greiner
1974-1978 Craig Reynolds
1979-1984 David Ernst
1979-1985 David McElligott
1980-1986 Jeffrey Kennedy
1983-1987 Henry Hunt
1986-1991 Ellen Klohe
1986-1992 Thomas Hickey
1986-1992 Ninette Robbins
1994-1999 Bennett Elzey

Areas of Research Interest and Current Projects

Tumor Immunology
Prostate Cancer
Gene Therapy
Cancer Metastasis
Effects of Stress on Immune Function

Current Projects

Vaccine Therapy of Prostate Cancer
Gene Therapy of Prostate Cancer
Effects of stress on immune function
Molecular mechanisms of metastasis in prostate cancer

Current Funding

2000-2005 Cellular activation in Prostate Cancer - VA Research Enhancement Award Program (REAP) $1,250,000
2002-2003 2nd International Conference on Prostate Cancer Research - NIH Conference Grant $28,000
2002-2006 Multiple Vaccine for therapy of Prostate Cancer -VA Merit Review $740,000

Professional Affiliations

American Association for the Advancement of Science
American Association of Immunologists
American Association for Cancer Research
Society for Basic Urologic Research
American Urological Association

Offices held in professional organizations

Executive Board; Society for Basic Urologic Research
Nominating Committee, Society for Basic Urologic Research
Chairman, Essay Contest, Society for Basic Urologic Research
Secretary, Society for Basic Urologic Research
Workshop Coordinator, Autumn Immunology Conference
Secretary, Autumn Immunology Conference
Chairman, Autumn Immunology Conference
Counselor, Autumn Immunology Conference
Advisor, Autumn Immunology Conference
Member of the Organizing Committee, International Symposium on the Biology of Prostate Growth
Member of the Organizing Committee, NIH Symposium on Bladder Physiology
Co-Chairman, American Urologic Association Basic Science Conference
Vice President, Society for Basic Urologic Research
President, Society for Basic Urologic Research
Chairman of the Organizing Committee, International Conference on Prostate Cancer Research
Member, Fall Symposium Organizing Committee, SBUR


Editorial Board of the journal, The Prostate
Ad Hoc Reviewer for: Journal of Immunology; the journal Transplantation; Laboratory Investigations; Journal of the National Cancer Institute, Journal of Andrology, Journal of Urology, Journal of Leukocyte Biology, Urology; the Journal of Physiology; NIH & VA Grants

Review panels

NIH Review Committees and Study Section - Special Review Committees on Prostate Growth, Molecular Epidemiology of Prostate Cancer; P01 Site Review Committees (Wistar, Univ. of Virginia, UCLA); Epidemiology and Disease Control-2 Study Section.
Other Grant Review Committees –
Department of Defense Prostate Cancer Research Program
National Aeronautics and Space Administration (NASA),
California Cancer Research Program.
American Cancer Society (ACS)

Peer-reviewed papers

  1. Lubaroff, DM & Ritts, RE In vitro cytotoxicity in delayed hypersensitivity of immunologic tolerance. Proc. Soc. Biol. Med., 116:823-827, 1964.
  2. Lubaroff, DM & Waksman, BH Delayed hypersensitivity: Bone marrow as source of cells in delayed skin reactions. Science, 157:322-323, 1967.
  3. Lubaroff, DM & Waksman, BH Bone marrow as source of cells in reactions of cellular hypersensitivity. I. Passive transfer of tuberculin sensitivity in syngeneic systems. J. Exp. Med., 128:1425-1435, 1968.
  4. Lubaroff, DM & Waksman, BH Bone marrow as source of cells in reactions of cellular hypersensitivity. II. Identification of allogeneic or hybrid cells by immunofluorescence in passively transferred tuberculin reactions. J. Exp. Med., 128:1437-1449, 1968.
  5. Putnam, DA, Lubaroff, DM & Waksman, BH Bone marrow as source of cells in reactions of cellular hypersensitivity. III. Adjuvant arthritis in rats. Arch. Rheumat., 12:215-219, 1969.
  6. Silvers, WK, Lubaroff, DM, Wilson, DB and Fox, D Mixed lymphocyte reactions and tissue transplantation tolerance. Science, 167:1264-1266, 1970.
  7. Lubaroff, DM & Silvers, WK The abolition of skin homografts in rats with isoantiserum. J. Immunol., 104:1236-1241, 1970.
  8. Lubaroff, DM & Silvers, WK Susceptibility of parental strain and F1 hybrid rats to runt disease. Transplant., 10:302-308, 1970.
  9. Lubaroff, DM & Silvers, WK Attempts to abolish tolerance of skin homografts in mice with x-irradiated plasma from specifically sensitized donors. J. Immunol., 106:1122-1124, 1971.
  10. Barker, CF, Lubaroff, DM and Silvers, WK Lymph Node Cells: Their differential capacity to induce tolerance of heart and skin homografts in rats. Science, 172:1050-1052, 1971.
  11. Silvers, WK, Lubaroff, DM and Johnson, JM Immunologic modifications of runt disease in rats. J. Nat. Cancer Inst., 49:1115-1119, 1972.
  12. Lubaroff, DM An alloantigenic marker on rat thymus and thymus-derived cells. Transplant. Proc., 5:115-118, 1973.
  13. Lubaroff, DM & Silvers, WK The importance of chimerism in maintaining tolerance of skin allografts in mice. J. Immunol., 111:65-71, 1973.
  14. Lubaroff, DM Cellular requirements for the rejection of skin allografts in rats. J. Exp. Med., 138:331-341, 1973.
  15. Lubaroff, DM, Canfield, L, Feldbush, TL and Bonney, WW R3327 adenocarcinoma of the Copenhagen rat as a model for the study of the immunologic aspects of prostatic cancer. J. Natl. Cancer Instit., 58:1677-1689, 1977.
  16. Lubaroff, DM Antigenic markers on rat lymphocytes. I. Characterization of A.R.T., an alloantigenic marker on rat thymus and thymus-derived cells. Cellular Immunology, 29:147-158, 1977.
  17. Feldbush, TL and Lubaroff, DM Fundamental Immunology. Seminars in Perinatology. 1:113, 1977.
  18. Lubaroff, DM Development of an epithelial cell line derived from human prostatic adenocarcinoma. J. Urology, 118:612-615, 1977.
  19. Lubaroff, DM - as part of a committee (T.J. Gill, III, chairman). Report of the First International Workshop on Alloantigenic Systems in the Rat. Transpl. Proc., 10:271-285, 1978.
  20. Lubaroff, DM, Canfield, L and Rasmussen, GT An animal model of human prostatic adenocarcinoma. Natl. Cancer Inst. Monograph, 49:275-281, 1978.
  21. Lubaroff, DM HPC-36, an epithelial tissue culture line derived from human prostate adenocarcinoma. Natl. Cancer Inst. Monograph, 49:35-39, 1978.
  22. Lande, IJ, Feldbush, TL, Lubaroff, DM and Bonney, WW Rat prostatic carcinoma 11095A: Antigenic profile (organ & tumor specific). Natl. Cancer Inst. Monograph, 49:283-287, 1978.
  23. Bonney, WW, Henstorf, JE, Emaus, SP, Lubaroff, DM and Feldbush, TL Immunostimulation by cryosurgery: An orthotopic model of prostate and bladder cancer in the rat. Natl. Cancer Inst. Monograph, 49:375-381, 1978.
  24. Lubaroff, DM and Culp, DA Experience with an animal model in the study of prostatic carcinoma. Trans. Amer. Assoc. G.U. Surg., 69:72-77, 1978.
  25. Lubaroff, DM, Reynolds, CW and Culp, DA Immunologic studies of prostatic cancer using the R3327 rat model. Trans. Amer. Assoc. of G.U. Surgeons, 70:60-63, 1979.
  26. Lubaroff, DM, Greiner, D.L. and Reynolds, C.W. Investigations of T-lymphocyte subpopulations in the rat using alloantigenic markers. Transpl. Proc., 11:1092-1094, 1979.
  27. Schlagel, C.J. and Lubaroff, DM Reactivity of Lewis lymph node and bone marrow cells to F344 Non-AgB histocompatibility antigens. Transpl. Proc., 11:1349-1350, 1979.
  28. Lubaroff, DM, Rasmussen, G.T. and Hunt, H.D. Comparative studies of T-lymphocyte antigens in the rat: Are A.R.T., Ly, Pta and AgF the same? Transpl. Proc., 11:1642-1645, 1979.
  29. Lubaroff, DM, et al. Second International Workshop on Alloantigenic Systems in the Rat: Combined Report on Reference Testing of Anti-T-Lymphocyte Alloantisera. Transpl. Proc., 11:1648-1649, 1979.
  30. Lubaroff, DM, Reynolds, C.W., and Canfield, L. Immunologic aspects of experimentally induced prostatic cancer. Cancer Detection and Prevention, 2:601-614, 1979.
  31. Lubaroff, DM, Canfield, L. and Reynolds, C.W. The Dunning Tumors. In: Model Systems for Prostatic Cancer. Alan Liss, Inc., N.Y., pp. 243-263, 1980.
  32. Lande, I.J., Feldbush, T.L. and Lubaroff, DM Studies on a weakly immunogenic squamous cell carcinoma of the rat prostate. Invest. Urol., 17:419-424, 1980.
  33. Lubaroff, DM, Greiner, D.L., Kunz, H.W. and Gill, T.J. III. Linkage of A.R.T.-2 with albinism in the rat. Rat News Letter, 6:14-16, 1980.
  34. Lubaroff, DM, Hunt, H.D. and Rasmussen, G.T. Separation of antibody specificities in the anti-A.R.T.-T cell sera. Transplant. Proc., 13:1453-1456, 1981.
  35. Greiner, D.L., Goldschneider, I., Barton, R.W. and Lubaroff, DM A quantitative assay system for thymocyte regeneration in the rat. Transplant. Proc., 13:1457-1459, 1981.
  36. Loening, S., Bonney, W., Fallon, B., Gerber, W., Hawtrey, C., Lubaroff, D., Narayana, A. and Culp, D. Perineal cryosurgery of prostate cancer. Urology, 17 (suppl):12-14, 1981.
  37. Lubaroff, DM, Reynolds, C.W., Canfield, L., McElligott, D., and Feldbush, T.L. Immunologic aspects of the prostate. The Prostate, 2:233-248, 1981.
  38. Lubaroff, DM, Reynolds, C.W. and Canfield, L. Immunologic Aspects of Experimentally Induced Prostatic Cancer. In: Prostatic Cancer. Marcel Dekker, Inc., p. 73-85, 1981.
  39. Greiner, D.L., Reynolds, C.W. and Lubaroff, DM Maturation of functional T lymphocyte subpopulations in the rat. Thymus, 4:77-90, 1982.
  40. Greiner, D.L., Barton, R.W., Goldschneider, I. and Lubaroff, DM Genetic linkage and cell distribution analysis of T cell alloantigens in the rat. J. Immunogenet., 9:43-50, 1982.
  41. Lubaroff, DM, Hunt, H.D. and Rasmussen, G.T. Serologic evidence that the ART-1 and LC antigens are separate and distinct molecules. Transpl. Proc., 15:1631, 1983.
  42. Lubaroff, DM, Ely, J.M. and Greiner, D.L. Monoclonal antibodies against the ART rat T cell antigens. Transpl. Proc., 15:1628, 1983.
  43. Ely, J.M., Greiner, D.L., Lubaroff, DM, and Fitch, F.W. Characterization of monoclonal antibodies which define rat T cell alloantigens. J. Immunol., 130:2798, 1983.
  44. Lubaroff, DM (Chairman of Nomenclature Committee). Standardized nomenclature for the rat T cell alloantigens. Transplant. Proc., 15:1683, 1983.
  45. Rowley, D.R., Thompson, S.A., Lubaroff, DM & Heidger, P.M. Androgen receptor binding characteristics of the rat dorsolateral prostate gland and the Dunning R3327 prostatic adenocarcinoma. The Prostate, 5:101, 1984.
  46. Loening, S.A. & Lubaroff, DM Cryosurgery and Immunotherapy of Prostatic Cancer. In: Urologic Clinics of North America 1984. W.B. Saunders, p. 327, 1984.
  47. Greiner, D.L., Goldschneider, I. and Lubaroff, DM Identification of thymocyte progenitors in hemopoietic tissues of the rat. Thymus, 6:181, 1984.
  48. Ernst, D.N. and Lubaroff, DM Membrane antigen phenotype of sensitized T lymphocytes mediating tuberculin delayed-type hypersensitivity in rats. Cellular Immunol. 88:436, 1984.
  49. Ernst, D.N., Kennedy, J.D., Hobbs, M.V., Morgan, E.L., Weigle, W.O., and Lubaroff, DM Potentiation of the rat delayed type hypersensitivity response by the Fc portion of human IgG1. Cellular Immunol., 89:445, 1984.
  50. Feldbush, T.L. and Lubaroff, DM "Immunotherapy of Cancer." In: Genitourinary Oncology (D.A. Culp and S.A. Loening, Eds.), Lea Febiger & Co., Philadelphia, pp. 158, 1985.
  51. Hunt, H.D. and Lubaroff, DM Interaction of T lymphocyte subpopulations bearing the RT6 alloantigen. Transplant Proc., 17:1861, 1985.
  52. Thompson, S.A., Johnson, M.P., Heidger, P.A. and Lubaroff, DM Heterogeneity in R3327 rat prostatic adenocarcinoma subcutaneous tumors derived from single cell clones. The Prostate, 6:369, 1985.
  53. Johnson, M.P., Thompson, S.A., and Lubaroff, DM Differential effects of prolactin on rat dorsolateral prostate in Dunning R3327 prostatic tumor sublines. J. of Urology, 133:1112, 1985.
  54. Lubaroff, DM, Hunt, H.D. and Rasmussen, G.T. Evidence from capping experiments for independence of the RT7 alloantigen and the leucocyte common antigen in the rat. J. of Immunogenetics, 12:239, 1985.
  55. Kennedy, J.D., Ernst, D.N. and Lubaroff, DM Investigation of T cells participating in the induction and regulation of delayed hypersensitivity reactions as identified by the expression of the RT6 alloantigen. Transplant. Proc., 19 (June):3181-3183, 1987.
  56. Hunt, H.D. and Lubaroff, DM Changes in membrane antigen phenotype of T cells during lectin activation. Transplant. Proc., 19(3):3179-3180, 1987.
  57. Mojcik, C.F., Greiner, D.L., Goldschneider, I. and Lubaroff, DM Monoclonal antibodies to RT7 and LCA antigens in the rat: Cell distribution and segregation analysis. Hybridoma 6(5):531-543, 1987.
  58. Lubaroff, DM, Rasmussen, G.T., and Hunt, H.D. The RT6 T cell antigen: Its role in the identification of functional subsets and in T cell activation. Transplantation Proceedings 21:3251, 1989.
  59. Ren, Z., Tucker, R., Landas, S., Lubaroff, DM, Sparrow, H.K., Loening, S.A. Regional hyperthermia combined with high energy shock wave treatment of Dunning prostate tumors. J Lithotripsy & Stone Dis 2(3):211-219, 1990.
  60. Baron, R.S., Cutrona, C.E., Hicklin, D., Russell, D.W., Lubaroff, DM Social support and immune function among spouses of cancer patients. Journal of Personality and Social Psychology 59(2):344-352, 1990.
  61. Donovan, J.F., Lubaroff, DM, and Williams, R.D. Immunotherapy of prostate cancer. Problems In Urology, Controversies in Prostate Cancer Management 4(3):489-505, 1990.
  62. Tucker, R.D., Loening, S.A., Landas, S.K., Mardan, A.H., Ren Z.Y., and Lubaroff, DM The in vivo effect of regional hyperthermia on Dunning R327 prostatic tumor. The Prostate 18:321-329, 1991.
  63. Richerson, H.B., Coon, J.D., Lubaroff, DM Experimental hypersensitivity pneumonitis in the rat: Histopathology and T cell subset compartmentalization. Am J Respira Cell & Molecular Biol, 5:451-463, 1991.
  64. Hunt, H.D., Lubaroff, DM Identification of functional T cell subsets and surface antigen changes during activation as they relate to RT6. Cellular Immunol., 143:194-211, 1992.
  65. Hayakawa, M, Lubaroff, DM, Williams, RD, and Osawa, A. Localization of LAK cells and IL-2-stimulated regional lymph node lymphocytes by regional arterial infusion in renal tumor-bearing rats. Urol Inter, 50:185-191, 1993.
  66. Cohen, MB, Heidger, P, and Lubaroff, DM Gross and macroscopic pathology of induced prostatic complex tumors arising in Lobund-Wistar rats. Cancer Res, 54:626-628, 1994.
  67. Richerson, HB, Coon, D, and Lubaroff, DM Adoptive transfer of experimental hypersensitivity pneumonitis in the LEW rat. Am J Resp Crit Care Med , 115:1205-1210 1995.
  68. Lubaroff, DM, Cohen, M, Shultz, LD, and Beamer, WG Survival of human prostate carcinoma, benign prostate tissues and IL2-activated lymphocytes in SCID mice.The Prostate, 27:32-41, 1995
  69. Richerson, HB, Coon, JD, and Lubaroff, DM Selective early increases of bronchoalveolar CD8+ lymphocytes in a LEW rat model of hypersensitivity pneuomonitis. J Allergy Clin Immunol, 96:113-121, 1995.
  70. Christensen, AJ, Edwards, DL, Wiebe, JS, Benotsch, EG, McKelvey, L, Andrews, MP, and Lubaroff, DM Effect of verbal self-disclosure on NK cell activity: Moderating influence of Cynical Hostility. Psychosomatic Medicine, 58:150-155, 1996.
  71. Cerhan, JR, Torner, JC, Lynch, CF, Rubenstein, LM, Lemke, JH, Cohen, MB, Lubaroff, DM, and Wallace, RB. Association of smoking, body mass, and physical activity with risk of prostate cancer in the Iowa 65+ Rural Health Study (United States). Cancer Causes and Control, 8:229-238, 1997.
  72. Harvey, HA, Ketterer, MR, Preston, A, Lubaroff, DM, Williams, RD, and Apicella, MA. Experimental infection of primary human urethral epithelial cell cultures by Neisseria gonorrheae. Infection & Immunity, 65:2420-2427, 1997.
  73. Heidger, PH, Lubaroff, DM, and Cohen, MB Fine structural studies of induced tumors arising within the prostatic complex of the Lobund-Wistar (L-W) rats. The Prostate 32:173-178 l997.
  74. Luo, J, Sharma, N, Seftor, EA, De Larco, J, Heidger, PM, Hendrix, JC, and Lubaroff, DM Heterogeneous expression of invasive and metastatic properties in a prostate tumor model. Path Oncol Rev, 3:264-271, 1997.
  75. Burns, JA, Kreder, KK, Lubaroff, DM, and See, WA. Alterations in constituent urinary proteins in response to bladder outlet obstruction in rats. J Urol, 159:1747-1751, 1998.
  76. Giardina, PC, Williams, RD, Lubaroff, D, and Apicella, MA. Neisseria gonorrheae induces focal polymerization of actin in primary human urethral epithelium. Infection & Immunity, 66:3416-3469, 1998.
  77. Sharma, N, Luo, J, Kirschmann, DA, O’Malley, Y, Robbins, MEC, Akporiaye, ET, Lubaroff, DM, Heidger, PH, and Hendrix, MJC. A novel immunological model for the study of prostate cancer. Cancer Research, 59:2271-2276, 1999.
  78. Luo, J, Lubaroff, DM, and Hendrix, MJC. Suppression of prostate cancer invasive potential and matrix metalloproteinase activity by E-cadherin transfection. Cancer Research, 59:3552-3556, 1999.
  79. Lutgendorf, SK, Garand, L., KC Buckwalter, Reimer, TT, Hong, S-Y, and Lubaroff, DM. Life stress, mood disturbance, and elevated interleukin-6 in healthy older women. J Gerontology, 54A:M434-439, 1999.
  80. Lutgendorf, SK, Vitaliano, PP, Reimer, TT, Harvey, JH, and Lubaroff, DM. Sense of coherence moderates the relationship between life stress and natural killer cell activity in healthy older adults. Psychology and Aging, 14:552-563,1999.
  81. Robbins, M, Ali, K, McCaw, R, Olsen, R, Vartak, S, and Lubaroff, D. ??-Linoleic acid (GLA)-mediated cytotoxicity in human prostate cancer cells. Adv. Exp Med Biol, 469:499-504, 1999.
  82. Lutgendorf, S.K., Anderson, B., Buller, R., Sorosky, J. & Lubaroff, D. Interleukin-6 and use of social support in gynecologic cancer patients. International Journal of Behavioral Medicine. 7:127-142, 2000.
  83. Lutgendorf, SK, Reimer, TT, Harvey, JH, Marks, G, Hong, S-Y, Hillis, SL, and Lubaroff, DM. Effects of housing relocation on immunocompetence and psychosocial functioning in older adults. Journal of Gerontology & Medical Sciences, 55A: ,2000.
  84. Lutgendorf, S, Logan, H, Kirchner, L, Rothrock, N, Svengalis, S, Iverson, K, and Lubaroff, D. Effects of relaxation and stress on the capsaicin-induced local inflammatory response. Psychosomatic Med, 62:524-534, 2000.
  85. Zenni, MK, Giardina, PC, Harvey, HA, Shao, J, Ketterer, MR, Lubaroff, DM, Williams, RD, and Apicella, MA. Macropinocytosis as a mechanism of entry into primary human urethral epithelial cells by Neisseria gonnorhoeae. Infection & Immunity, 68:1696-1699, 2000.
  86. Logan H, Lutgendorf S, Rainville P, Sheffield D, Iverson K, Lubaroff D: Effects of Stress and Relaxation on Capsaicin-Induced Pain. J of Pain, 2:160-170, 2001.
  87. Logan, HL Lutgendorf, S Kirchner, HL Rivera, EM Lubaroff, D Pain and Immunologic Response to Root Canal Treatment and Subsequent Health Outcomes. Psychosomatic Med, 63:453-462, 2001.
  88. Siemens, DR, Elzey, BD, Lubaroff, DM, and Ratliff, TL. Restoration of the ability to generate CTL in mice immune to adenovirus by delivery of virus in a collagen-based matrix. J Immunol, 166:731-735, 2001
  89. Elzey, BD, Ratliff, TL and Lubaroff, DM. Immunization with Type 5 Adenovirus Recombinant for PSA In Combination with ALVAC Cytokine Gene Delivery Induces Destruction of Established Prostate Tumors. Int. J. Cancer, 94:842-849, 2001.
  90. Sharma, N, Seftor, REB, Seftor, EA, Gruman, LM, Heidger, PM, Cohen, MB, Lubaroff, DM, and Hendrix, MJC. Prostatic tumor cell plasticity involves cooperative interactions of distinct phenotypic subpopulations: Role in vasculogenic mimicry. Prostate, 50:189-201, 2002.
  91. Garand L. Buckwalter KC. Lubaroff D. Tripp-Reimer T. Frantz RA. Ansley TN. A pilot study of immune and mood outcomes of a community-based intervention for dementia caregivers: the PLST intervention. Archives of Psychiatric Nursing. 16:156-67, 2002
  92. Lubaroff, DM and Acosta, AM. Animal Models of Prostate Cancer. In: Molecular and Cell Biology of Prostate Cancer (Abel, Ed.) 2003
  93. Helpap B. Schmitz-Drager BJ. Hamilton PW. Muzzonigro G. Galosi AB. Kurth KH. Lubaroff D. Waters DJ. Droller MJ. Molecular pathology of non-invasive urothelial carcinomas (part I). Virchows Archiv. 442(4):309-16, 2003
  94. Lutgendorf, SK, Logan, H, Costanza, E, and Lubaroff, D. Effects of acute stress, relaxation, and a neurogenic inflammatory stimulus on interleukin-6 in humans. Brain, Behavior, & Immunity, 18:55-64, 2004
  95. Chunthapong, J., Seftor, E.A., Heidger, P.M., Jr., Khalkhali-Ellis, Z., Kirschman, D.A., Amir, S., Lubaroff, D.M., and Hendrix, M.J.C. Dual roles of E-cadherin in prostate cancer invasion. J Cellular Biochemistry, 91:649-661, 2004
  96. Hendrix, MJC, Luo, J, Seftor, EA, Sharma, N, Heidger, PM, Cohen, MB, Bhatty, R, Chungthapong, J, Seftor, REB, and Lubaroff, D. Epithelial-Mesenchymal molecular interactions in prostate tumor cell plasticity. In: Cancer Metastasis – Biology and Treatment (Ablin and Mason, Eds.). Kluwer, In Press
  97. Lubaroff, DM, Karan, D, Andrews, MP, Acosta, A, Abouassaly, C, Sharma, M, and Krieg, AM. Decreased Cytotoxic T cell Activity Generated by Co-administration of PSA Vaccine and CpG ODN is Associated with Increased Tumor Protection in a Mouse Model of Prostate Cancer. Submitted for publication
  98. Lubaroff, DM, Konety, B, Link, BK, Ratliff, TL, and Williams, RD. A Phase I study of an adenovirus/PSA vaccine in men with metastatic prostate cancer. In preparation.
  99. Karan, D and Lubaroff, DM. Mechanism of CpG modulation of vaccine-induced anti-prostate tumor immunity. In preparation.
  100. Lubaroff, DM, Konety, B, Link, BK, and Williams, RD. Safety data from a Phase I trial of an adenovirus/PSA vaccine in men with metastatic prostate cancer. In preparation.
  101. Lubaroff, DM, Boeglin, D, Howard, J, Jensen, R, and Ratliff, TL. Measurement of immune responses in prostate cancer patients enrolled in a Phase I clinical trial of an adenovirus/PSA vaccine. In preparation.
  102. Lutgendorf, SK, Sood, A, Anderson, B, McGinn, S, Mais eri, H, Dao, M, Sorosky, J, De Geest, K, and Lubaroff, DM. Biobehavioral correlates of natural killer cell cytotoxicity in ovarian cancer patients. In preparation.